Pioneering Inc. Flagship serves as Executive at Omega Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Pioneering Inc. Flagship has executed 11 insider transactions totaling $39.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 27, 2023 involved purchasing 1,993,986 shares valued at $11.5M.
Pioneering Inc. Flagship currently holds 7,508,693 shares of Omega Therapeutics, Inc. (OMGA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pioneering Inc. Flagship has been a net buyer of OMGA stock. They have purchased $39.2M and sold $0 worth of shares.
Pioneering Inc. Flagship's most recent insider trade was on Feb 27, 2023, when they purchased 1,993,986 shares at $5.78 per share.
Get notified when new Form 4 filings are submitted
| $5.78 |
| Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 970,588 | $N/A | Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 1,323,529 | $N/A | Discretionary |
| Aug 3, 2021 | OMGA | $11.2M | Purchase | 661,764 | $17.00 | Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 4,852,943 | $N/A | Discretionary |
| Aug 3, 2021 | OMGA | $5.0M | Purchase | 294,117 | $17.00 | Discretionary |
| Aug 3, 2021 | OMGA | $3.7M | Purchase | 220,588 | $17.00 | Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 8,396,825 | $N/A | Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 5,896,386 | $N/A | Discretionary |
| Aug 3, 2021 | OMGA | $0 | Conversion | 1,088,470 | $N/A | Discretionary |